A Diet Containing Animal Source Protein as Fresh, Lean Beef Is More Well Liked and Promotes Healthier Eating Behavior Compared with Plant-Based Alternatives in Women with Overweight.
含有新鮮瘦牛肉等動物來源蛋白的飲食在超重女性中比植物性替代品更受喜愛，並促進更健康的飲食行為。
Curr Dev Nutr 2024-09-03
Early Conversion of Intensive Insulin Therapy to IDegLira Demonstrates Higher Efficacy and Safety in Reducing Fasting Blood Glucose and HbA1c in T2DM Patients.
早期將強化胰島素療法轉換為IDegLira在降低2型糖尿病患者的空腹血糖和HbA1c方面顯示出更高的療效和安全性。
Diabetes Metab Syndr Obes 2024-09-03
The effectiveness and sustainability of health outcomes from a holistic digital weight-loss service with concomitant initiation of tirzepatide: A pragmatic randomized controlled trial in the UK.
全方位數位減重服務結合 tirzepatide 啟動的健康結果有效性與可持續性：英國的一項務實隨機對照試驗。
Diabetes Obes Metab 2024-09-03
Use of GLP-1 receptor agonists for the management of type 1 diabetes: A pediatric perspective.
GLP-1 受體激動劑在 1 型糖尿病管理中的應用：兒科觀點。
Horm Res Paediatr 2024-09-02
In early Parkinson disease, daily subcutaneous lixisenatide reduced motor disability progression at 12 mo.
早期帕金森病中，每日皮下注射lixisenatide可在12個月內減少運動障礙的進展。
Ann Intern Med 2024-09-02
Mortality and Serious Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists: A Pharmacovigilance Study Using the FDA Adverse Event Reporting System.
與胰高血糖素樣肽-1受體激動劑相關的死亡率和嚴重不良事件：使用FDA不良事件報告系統的藥物監測研究。
Cureus 2024-09-02
The GLP-1 receptor agonist exendin-4 reduces taurine and glycine in nucleus accumbens of male rats, an effect tentatively involving the nucleus tractus solitarius.
GLP-1 受體激動劑 exendin-4 減少雄性大鼠腹側被蓋核中的牛磺酸和甘氨酸，這一效果暫時涉及孤束核。
Front Pharmacol 2024-09-02